BIOMOTION PHARMA ApS — Credit Rating and Financial Key Figures

BIOMOTION PHARMA ApS (CVR number: 12928203) is a company from KØBENHAVN. The company recorded a gross profit of -5.3 kDKK in 2024. The operating profit was -5.3 kDKK, while net earnings were -6.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -56.5 %, which can be considered poor and Return on Equity (ROE) was -98.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 42.4 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. BIOMOTION PHARMA ApS's liquidity measured by quick ratio was 1.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.